Thermo Fisher Scientific (TMO) fundamentals: P/E, valuation, undervalued?
Thermo Fisher Scientific · Health Care · ref. ETF XLV · price $663.04
In short — Thermo Fisher Scientific trades at 35.7× earnings (P/E), 24.0× forward, with a net margin of 15.0 % and revenue growth of +11 %. Read: High P/E (P/E 36 (above average)).
Is Thermo Fisher Scientific stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$663.04+26.1% over range
Oct 14, 25low $438.34 · high $679.61Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
73% recommend buying · 11 analysts
Valuation : High P/E — P/E 36 (above average)
Valuation
35.7
P/E (price/earnings)
24.0
Forward P/E
3.80
PEG
4.7
Price/book (P/B)
$245.2B
Market cap
18.58
EPS
Profitability & growth
15.0 %
Net margin
+11 %
Revenue growth
+9 %
Earnings growth
$42.5B
Total debt
Thermo Fisher Scientific income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $44.9B | $7.0B | 15.5 % |
| 2023 | $42.9B | $6.0B | 14.0 % |
| 2024 | $42.9B | $6.3B | 14.8 % |
| 2025 | $44.6B | $6.7B | 15.0 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Thermo Fisher Scientific's P/E and is the stock undervalued? What's a good P/E?
Thermo Fisher Scientific's P/E is 35.7 (forward 24.0). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "High P/E".
Is Thermo Fisher Scientific profitable?
Thermo Fisher Scientific has a net margin of 15.0 % (EPS 18.58). The company is profitable.
Is TMO stock expensive?
Our read: "High P/E" — P/E 36 (above average). Cross-check with growth and sector.
💬 A question about Thermo Fisher Scientific? The JPI assistant answers using our backtest data.
Keep exploring Thermo Fisher Scientific